CLINICAL_TRIALS
trial_result
· 2016-02-02
Clinical Trial Update: Dacarbazine and Carmustine in Metastatic Melanoma [Phase 2]
Summary
Phase 2 trial evaluating dacarbazine and carmustine in metastatic melanoma was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Western Regional Medical Center | Conditions: Melanoma Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2016-02-02